Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous aqueous progesterone injection II vs vaginal progesterone gel for luteal support in HRT-FET
ChiCTR2600129138Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of progesterone in infertility (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: ongoing pregnancy rate. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2600129138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129138.